140 related articles for article (PubMed ID: 32655941)
1. Cabozantinib, a Multityrosine Kinase Inhibitor of MET and VEGF Receptors Which Suppresses Mouse Laser-Induced Choroidal Neovascularization.
Zhang X; Zhu M; Xie L; Sun X; Xu J; Guo Y; Liu D; Shi Y; Xu X; Song E
J Ophthalmol; 2020; 2020():5905269. PubMed ID: 32655941
[TBL] [Abstract][Full Text] [Related]
2. Brivanib, a multitargeted small-molecule tyrosine kinase inhibitor, suppresses laser-induced CNV in a mouse model of neovascular AMD.
Li L; Zhu M; Wu W; Qin B; Gu J; Tu Y; Chen J; Liu D; Shi Y; Liu X; Sang A; Ding D
J Cell Physiol; 2020 Feb; 235(2):1259-1273. PubMed ID: 31270802
[TBL] [Abstract][Full Text] [Related]
3. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
4. Fruquintinib inhibits VEGF/VEGFR2 axis of choroidal endothelial cells and M1-type macrophages to protect against mouse laser-induced choroidal neovascularization.
Liu X; Guo A; Tu Y; Li W; Li L; Liu W; Ju Y; Zhou Y; Sang A; Zhu M
Cell Death Dis; 2020 Nov; 11(11):1016. PubMed ID: 33247124
[TBL] [Abstract][Full Text] [Related]
5. Prodrug of epigallocatechin-3-gallate alleviates choroidal neovascularization via down-regulating HIF-1α/VEGF/VEGFR2 pathway and M1 type macrophage/microglia polarization.
Xu J; Tu Y; Wang Y; Xu X; Sun X; Xie L; Zhao Q; Guo Y; Gu Y; Du J; Du S; Zhu M; Song E
Biomed Pharmacother; 2020 Jan; 121():109606. PubMed ID: 31743875
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of RACK1 ameliorates choroidal neovascularization formation in vitro and in vivo.
Liu X; Zhu M; Yang X; Wang Y; Qin B; Cui C; Chen H; Sang A
Exp Mol Pathol; 2016 Jun; 100(3):451-9. PubMed ID: 27112838
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal itraconazole inhibits laser-induced choroidal neovascularization in rats.
Bae JH; Hwang AR; Kim CY; Yu HG; Koh HJ; Yang WI; Chang HR; Lee SC
PLoS One; 2017; 12(6):e0180482. PubMed ID: 28666022
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal injection of resveratrol inhibits laser-induced murine choroidal neovascularization.
Zhang HM; Li XH; Chen M; Luo J
Int J Ophthalmol; 2020; 13(6):886-892. PubMed ID: 32566498
[TBL] [Abstract][Full Text] [Related]
10. Axitinib inhibits retinal and choroidal neovascularization in in vitro and in vivo models.
Giddabasappa A; Lalwani K; Norberg R; Gukasyan HJ; Paterson D; Schachar RA; Rittenhouse K; Klamerus K; Mosyak L; Eswaraka J
Exp Eye Res; 2016 Apr; 145():373-379. PubMed ID: 26927930
[TBL] [Abstract][Full Text] [Related]
11. Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina.
Balser C; Wolf A; Herb M; Langmann T
J Neuroinflammation; 2019 Feb; 16(1):26. PubMed ID: 30732627
[TBL] [Abstract][Full Text] [Related]
12. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
[TBL] [Abstract][Full Text] [Related]
13. Activator of G-protein signaling 8 is involved in VEGF-induced choroidal neovascularization.
Hayashi H; Mamun AA; Takeyama M; Yamamura A; Zako M; Yagasaki R; Nakahara T; Kamei M; Sato M
Sci Rep; 2019 Feb; 9(1):1560. PubMed ID: 30733465
[TBL] [Abstract][Full Text] [Related]
14. Annexin A2 promotes choroidal neovascularization by increasing vascular endothelial growth factor expression in a rat model of argon laser coagulation-induced choroidal neovascularization.
Zhao SH; Pan DY; Zhang Y; Wu JH; Liu X; Xu Y
Chin Med J (Engl); 2010 Mar; 123(6):713-21. PubMed ID: 20368092
[TBL] [Abstract][Full Text] [Related]
15. PKR promotes choroidal neovascularization via upregulating the PI3K/Akt signaling pathway in VEGF expression.
Zhu M; Liu X; Wang S; Miao J; Wu L; Yang X; Wang Y; Kang L; Li W; Cui C; Chen H; Sang A
Mol Vis; 2016; 22():1361-1374. PubMed ID: 27994435
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD.
Wei X; Zhang T; Yao Y; Zeng S; Li M; Xiang H; Zhao C; Cao G; Li M; Wan R; Yang P; Yang J
Exp Eye Res; 2018 Mar; 168():2-11. PubMed ID: 29284110
[TBL] [Abstract][Full Text] [Related]
17. Arg-Leu-Tyr-Glu Suppresses Retinal Endothelial Permeability and Choroidal Neovascularization by Inhibiting the VEGF Receptor 2 Signaling Pathway.
Park W; Baek YY; Kim J; Jo DH; Choi S; Kim JH; Kim T; Kim S; Park M; Kim JY; Won MH; Ha KS; Kim JH; Kwon YG; Kim YM
Biomol Ther (Seoul); 2019 Sep; 27(5):474-483. PubMed ID: 31042676
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal Stanniocalcin-1 Enhances New Blood Vessel Growth in a Rat Model of Laser-Induced Choroidal Neovascularization.
Zhao M; Xie W; Tsai SH; Hein TW; Rocke BA; Kuo L; Rosa RH
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1125-1133. PubMed ID: 29490350
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
20. Suppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitor.
Takeda A; Hata Y; Shiose S; Sassa Y; Honda M; Fujisawa K; Sakamoto T; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2003 Sep; 241(9):765-72. PubMed ID: 12937991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
